ScholarIQanswers from OpenAlex
Mersana Therapeutics
FunderResearch funding and supported work
Mersana Therapeutics is a funder indexed in ScholarIQ from OpenAlex.
What is known about Mersana Therapeutics?
ScholarIQrecord summary
company in Cambridge, United States
How many works does Mersana Therapeutics have?
ScholarIQindexed works
Mersana Therapeutics has 469 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Mersana Therapeutics?
ScholarIQopenalex
The OpenAlex for Mersana Therapeutics is on the source record.
What is the ROR of Mersana Therapeutics?
ScholarIQror
The ROR for Mersana Therapeutics is on the source record.
What are the most-cited papers on Mersana Therapeutics?
ScholarIQmost cited works
Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial
B.J. Monk, Maria Pilar Barretina-Ginesta, Bhavana Pothuri, Ignace Vergote, Whitney A. Spannuth Graybill, Mansoor Raza Mirza, C. C. McCormick, Domenica Lorusso, Richard G. Moore, Gilles Freyer, Roisin E. O’Cearbhaill, Florian Heitz, David M. O’Malley, Andrés Redondo, Mark S. Shahin, Christof Vulsteke, William H. Bradley, Charlotte Aaquist Haslund, Dana M. Chase, Carmela Pisano, L.L. Holman, M.J. Rubio Pérez, Paul DiSilvestro, Lydia Gaba, Thomas J. Herzog, Ilan Bruchim, Natalie Compton, L. Shtessel, Izabela A. Malinowska, Antonio González-Martı́n
Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial
Giorgio Valabrega, Bhavana Pothuri, Ana Oaknin, Whitney S. Graybill, Ana Beatriz Sánchez, Colleen McCormick, Jean‐François Baurain, Anna V. Tinker, Hannelore Denys, Roisin E. O’Cearbhaill, Sakari Hietanen, Richard G. Moore, Anja Ør Knudsen, Thibault de La Motte Rouge, Florian Heitz, Tally Levy, Whitney York, Divya Gupta, Bradley J. Monk, Antonio González-Martı́n